JK

Jayshree Krishnaswami

Senior Director Clinical Operations at Mirum Pharmaceuticals

Jayshree Krishnaswami has extensive experience in clinical operations, having held various leadership roles in multiple pharmaceutical companies. Jayshree is currently working as a Senior Director of Clinical Operations at Mirum Pharmaceuticals, Inc. since January 2024. Prior to that, they served as Director of Clinical Operations at Mirum Pharmaceuticals, Inc. from January 2021 to December 2023. Jayshree also held positions such as Director of Clinical Operations at Retrotope, Inc. from July 2019 to January 2021, Director of Clinical Operations at Immune Design from October 2018 to July 2019, and Associate Director of Clinical Operations at Acorda Therapeutics, Inc. from January 2016 to April 2018. Before that, they worked as a Senior Clinical Program Manager at Biotie Therapies, Inc. from March 2015 to January 2016, and as a Senior CTM Consultant at Exelixis from April 2014 to March 2015. Additionally, they gained experience at Quintiles where they held various roles including Senior Clinical Project Manager from June 2011 to December 2013, Clinical Study Manager from April 2008 to June 2011, and Clinical Team Lead from July 2006 to March 2008. Furthermore, Jayshree had earlier positions at Quintiles as a Clinical Team Lead from January 2004 to August 2005, and as a Clinical Research Associate from May 2001 to December 2003, where they conducted clinical monitoring and served as the primary contact for site management and sponsor communication.

Jayshree Krishnaswami completed a Bachelor's degree in Chemistry from St. Xavier's College in India from 1993 to 1996. Following that, they pursued a Post Graduate Diploma in Business Management with a focus on Marketing from the Som Lalit Institute of Management Studies in India between 1998 and 2000.

Links

Previous companies

Acorda Therapeutics logo
Exelixis logo
IQVIA logo
Retrotope logo

Timeline

  • Senior Director Clinical Operations

    January, 2024 - present

  • Director Clinical Operations

    January, 2021